candesartan has been researched along with Abnormalities, Multiple in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, RM | 1 |
| Anderson, JM | 1 |
| Cox, P | 1 |
1 other study available for candesartan and Abnormalities, Multiple
| Article | Year |
|---|---|
Defective embryogenesis with angiotensin II receptor antagonists in pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Angiotensin Receptor Antagonists; Antih | 2003 |